Junko H. Ohyashiki

Tokyo, 1600023, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Hypoxia-induced paclitaxel resistance in cervical cancer modulated by miR-100 targeting of USP15.

Hypoxia-induced paclitaxel resistance in cervical cancer modulated by miR-100 targeting of USP15.

Journal: Gynecologic oncology reports
Published: November 21, 2022

Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma.

Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma.

Journal: Haematologica
Published: November 09, 2019

Effect of the extracellular component of bone marrow mesenchymal stromal cells from healthy donors on hematologic neoplasms and their angiogenesis.

Effect of the extracellular component of bone marrow mesenchymal stromal cells from healthy donors on hematologic neoplasms and their angiogenesis.

Journal: Human cell
Published: September 30, 2019

Downregulation of extracellular vesicle microRNA-101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression.

Downregulation of extracellular vesicle microRNA-101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression.

Journal: Oncology letters
Published: July 04, 2019

Induction of multiple myeloma bone marrow stromal cell apoptosis by inhibiting extracellular vesicle miR-10a secretion.

Induction of multiple myeloma bone marrow stromal cell apoptosis by inhibiting extracellular vesicle miR-10a secretion.

Journal: Blood advances
Published: May 07, 2019

BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma.

BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma.

Journal: Leukemia & lymphoma
Published: November 28, 2018

Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement.

Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement.

Journal: Bone marrow transplantation
Published: November 21, 2018

A novel non-invasive monitoring assay of 5-azacitidine efficacy using global DNA methylation of peripheral blood in myelodysplastic syndrome.

A novel non-invasive monitoring assay of 5-azacitidine efficacy using global DNA methylation of peripheral blood in myelodysplastic syndrome.

Journal: Drug design, development and therapy
Published: November 18, 2018

Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.

Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.

Journal: International journal of molecular sciences
Published: July 27, 2018

Chromatin Regulation by HP1γ Contributes to Survival of 5-Azacytidine-Resistant Cells.

Chromatin Regulation by HP1γ Contributes to Survival of 5-Azacytidine-Resistant Cells.

Journal: Frontiers in pharmacology
Published: June 30, 2018

Hidden FLT3-D835Y clone in FLT3-ITD-positive acute myeloid leukemia that evolved into very late relapse with T-lymphoblastic leukemia.

Hidden FLT3-D835Y clone in FLT3-ITD-positive acute myeloid leukemia that evolved into very late relapse with T-lymphoblastic leukemia.

Journal: Leukemia & lymphoma
Published: October 04, 2017

Extracellular vesicle-mediated cell-cell communication in haematological neoplasms.

Extracellular vesicle-mediated cell-cell communication in haematological neoplasms.

Journal: Philosophical transactions of the Royal Society of London. Series B, Biological sciences
Published: April 15, 2017
Showing 1-12 of 40

Last Updated: 09/26/2026